Get started
Author

Ezgi Avanaz

Observed name: Ezgi AVANAZ
ORCID: 0009-0002-7974-4514
Observed ORCID: 0009-0002-7974-4514
OpenAlex ID: A5017164853
Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry
2026 · Serap Yadigar, Suat Akgür, et al. · Cardiovascular Drugs and Therapy · 1
PDF
Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study
2026 · Serap Yadigar, Suat Akgür, et al. · BMC Nephrology · 1
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort
2026 · Murat Özdede, Serap Yadigar, et al. · Clinical Kidney Journal · 1
Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study
2026 · Alper Tuna Güven, Serap Yadigar, et al. · Journal of Clinical Medicine
PDF
Predicting Postoperative Serum Creatinine Levels in Living Donor Kidney Transplantation: The Role of Donor–Recipient Muscle Mass Differences
2025 · Ezgi Avanaz, Ali Avanaz · Transplantation Proceedings
Demographic, Clinical and Treatment Characteristics of Patients with Hepatocellular Cancer: 10 Years of Experience of a Single Center
2023 · Ezgi AVANAZ, Dinç DİNÇER, et al. · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
PDF
Evaluation of Overall Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma and Comparison of Living Versus Deceased Donor Liver Transplants: Results of 15 Years of Experience
2023 · Ali Avanaz, Haydar Adanir, et al. · Eurasian Journal of Medicine
Diagnosis and treatment of splenic artery steal syndrome after liver transplantation
2021 · Ali Avanaz, Ezgi Avanaz, et al. · Surgical Practice
Works count: 8
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type